Bingsong Han

机构：Biogen (United States)

发表论文 17 篇 · 总被引 708 次 · h-index 12

代表论文

• Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6 (2017 · Cell Reports · 被引 208)
• Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors (2013 · Journal of Medicinal Chemistry · 被引 82)
• Structure-Based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors (2013 · Journal of Medicinal Chemistry · 被引 74)
• Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities (2020 · ACS Medicinal Chemistry Letters · 被引 72)
• Discovery of novel N-hydroxy-2-arylisoindoline-4-carboxamides as potent and selective inhibitors of HDAC11 (2018 · Bioorganic & Medicinal Chemistry Letters · 被引 67)
• Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT) (2013 · Bioorganic & Medicinal Chemistry Letters · 被引 45)